Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
BYSTOLIC
Generic name / active ingredient
nebivolol tablets
Dosage-form class
Nebivolol hydrochloride oral tablets: 2.5 mg, 5 mg, 10 mg and 20 mg; four triangular unscored tablets and exact U.S. bottle identities
Route
Oral
Record reviewed
2026-08-30

Copy from the pack in hand

Source-linked reading points

  • 2.5, 5, 10 and 20 mg are labelled nebivolol amounts per tablet. '30' or '90 Tablets' is the bottle count, not the amount per dose. An unscored appearance is an identity clue and does not let the site infer self-splitting permission.
  • The label warns against abruptly stopping BYSTOLIC, especially with coronary artery disease, because abrupt beta-blocker withdrawal may worsen angina or myocardial-infarction risk. Do not stop from one pulse or blood-pressure reading; use local emergency care for chest pain or another severe acute symptom.
  • If another beta blocker (such as TOPROL-XL, LOPRESSOR/metoprolol, bisoprolol, TENORMIN, INDERAL LA or COREG), digoxin, diltiazem/verapamil or clonidine appears on the list, ask a pharmacist or prescriber to prioritise duplicate effects, heart rate, conduction and hypotension risk.
  • The label says nebivolol may mask some warning features of hypoglycaemia; a person with diabetes should not rely only on a racing heart to detect low glucose. Fainting, severe bradycardia, breathing difficulty, swelling of the face/lips/tongue/throat or persistent chest pain requires prompt medical assessment; severe acute features require local emergency care.

Reviewed presentation examples — compare every field

  • 2.5 mg nebivolol per tablet (as hydrochloride); 30-tablet bottleNDC 0456-1402-30
  • 5 mg nebivolol per tablet (as hydrochloride); 90-tablet bottleNDC 0456-1405-90
  • 10 mg nebivolol per tablet (as hydrochloride); 90-tablet bottleNDC 0456-1410-90
  • 20 mg nebivolol per tablet (as hydrochloride); 90-tablet bottle; FDA RSNDC 0456-1420-90

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-30
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image